Digestive & Intestinal Remedies (Pharmacies) - Central Asia

  • Central Asia
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$163.60m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 8.87%, resulting in a market volume of US$250.20m by 2029.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$2.06 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Central Asia is experiencing significant growth and development. Customer preferences in the region are driving the demand for digestive and intestinal remedies. Central Asian consumers are increasingly becoming aware of the importance of digestive health and are seeking remedies to address common gastrointestinal issues. This is leading to a higher demand for products such as antacids, laxatives, and anti-diarrheal medications. Additionally, the rising middle class in Central Asia has more disposable income to spend on healthcare products, further fueling the growth of the market. One of the key trends in the market is the increasing popularity of natural and herbal remedies. Central Asian consumers have a long history of using traditional herbal medicines to treat various ailments, including digestive issues. As a result, there is a growing demand for natural and herbal digestive remedies in the region. Manufacturers are responding to this trend by introducing a wide range of natural and herbal products to cater to the preferences of the local consumers. Another trend in the market is the growing availability of digestive and intestinal remedies in pharmacies. Pharmacies are expanding their product offerings to meet the rising demand for these products. They are stocking a wider variety of digestive and intestinal remedies, including both over-the-counter and prescription medications. This increased availability makes it easier for consumers to access the products they need to manage their digestive health. Local special circumstances in Central Asia also contribute to the development of the Digestive & Intestinal Remedies market. The region has a diverse population with different dietary habits and lifestyles, which can contribute to digestive issues. Additionally, Central Asia is known for its spicy and heavy cuisine, which can also lead to gastrointestinal problems. These factors create a high demand for digestive and intestinal remedies in the region. Underlying macroeconomic factors also play a role in the growth of the market. Central Asia has been experiencing economic growth in recent years, which has led to an increase in disposable income and improved healthcare infrastructure. As a result, consumers have more money to spend on healthcare products, including digestive and intestinal remedies. The improved healthcare infrastructure also means that consumers have better access to healthcare services and products, further driving the growth of the market. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Central Asia is developing due to customer preferences for digestive health products, the increasing popularity of natural and herbal remedies, the growing availability of these products in pharmacies, local special circumstances, and underlying macroeconomic factors.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)